
Who's online
There are currently 5 users and 241 guests online.
Online users
- Inga
- Bart Knols
- Moon
- patrick sampao
- Kabogo
News Flash
Latest Jobs
Events 2010
Recent blog posts
- Job: Postdoctoral Fellow: Malaria transmission-blocking research (Entomologist/Malariologist)
- Job: ACT Consortium Policy Liaison Officer
- Harnessing Immunity Genes Against Plasmodium: The Series
- We thought we were down to 655.000 deaths in 2010, right?
- Job: Postdoctoral Fellow: Malaria resistance research
- Let the sun shine
- Postdoctoral Fellows: Malaria research
- Guest Editorial: Don't fake it!
- Loop mediated amplification question
- Criticism, Ideas and the Maya example
Bhutan has made significant strides towards elimination and has adopted a goal of national elimination.
Malaria is one of the deadliest infectious diseases in the world, with the eukaryotic parasite Plasmodium falciparum causing the most severe form of the disease.
Contrary to conventional low transmission models, this study provides evidence of a parasite population structure that is superficially defined by a clonal backbone.
Naturally acquired blood-stage infections of the malaria parasite Plasmodium falciparum typically harbour multiple haploid clones.
The ligands that pathogens use to invade their target cells have often proven to be good targets for vaccine development.
Plasmodium yoelii YM asexual blood stage parasites express multiple members of the py235 gene family, part of the super-family of genes including those coding for Plasmodium vivax reticulocyte binding proteins and Plasmodium falciparum RH proteins.
The data showed that the implementation IPT using SP in children needs to be reviewed.
The aim of this Phase I/IIa double-blind controlled trial was to test the efficacy of the sporozoite-based malaria vaccine PfCS 282–383 (PfCS102) to protect against Plasmodium falciparum parasitaemia.
We have previously shown that a "reversed chloroquine (RCQ)" molecule, composed of a chloroquine-like moiety and a resistance reversal-like moiety, can overcome chloroquine resistance in P. falciparum
In this study, a recombinant P. falciparum coproporphyrinogen III oxidase (rPfCPO) was produced in E. coli and confirmed to be active under aerobic conditions.